Cited by 33Retinal Imaging and AnalysisRetinal Diseases and TreatmentsOphthalmology and Visual Health Research

Feasibility of screening for diabetic retinopathy using artificial intelligence, Brazil

Open access
Korn Malerbi, Fernando, Barreto Melo, Gustavo·2022·Bulletin of the World Health Organization

Abstract

Problem: There is currently no national strategy or standardized approach to diabetic retinopathy screening in the Brazilian public health system, and multiple socioeconomic barriers prevent access to eye examination in Brazil's poorest regions. Approach: From September 2021 to March 2022 we carried out a pilot project with an artificial intelligence system for diabetic retinopathy screening, embedded in a portable retinal camera. Patients with a diagnosis of diabetes according to the municipality registry were invited to attend nearby clinics for screening on designated days. Trained health-care technicians acquired images which were automatically evaluated by the system, with instant remote evaluation by retinal specialists in selected cases. Local setting: Our study was based in Sergipe State, located at a region with high illiteracy rates and no local availability of specialized retina care. The average number of laser treatments performed annually in the last 5 years is 126, for a total State population of 2.3 million. Relevant changes: Even though screening was performed free of charge in a convenient location for patients, from a total 2052 eligible individuals, only 1083 attended for screening. Lessons learnt: Efforts to raise awareness on the condition screened and to provide health education for patients and local health-care personnel are fundamental for increased attendance. Tailoring screening systems to the local setting, such as determining the trade-off between sensitivity and specificity, is challenging in regions with no current benchmarks. Standards for retinopathy screening based on the strategies adopted by high-income countries may not be realistic in low- and middle-income countries.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2471/blt.22.288580

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 13

  1. [1]Mathenge W, Whitestone N, Nkurikiye J, Patnaik JL, Piyasena P, Uwaliraye P, et al. Impact of artificial intelligence assessment of diabetic retinopathy on referral service uptake in a low resource setting: The RAIDERS randomized trial. Ophthalmology Science; 2022. 10.1016/j.xops.2022.100168 PMC9754978 36531575 · DOI · Paper page
  2. [3]Silva PS, Aiello LP. Telemedicine and eye examinations for diabetic retinopathy: a time to maximize real-world outcomes. JAMA Ophthalmol. 2015 May; 133(5): 525– 6. 10.1001/jamaophthalmol.2015.0333 25742322 · DOI
  3. [4]Ruamviboonsuk P, Tiwari R, Sayres R, Nganthavee V, Hemarat K, Kongprayoon A, et al. Real-time diabetic retinopathy screening by deep learning in a multisite national screening programme: a prospective interventional cohort study. Lancet Digit Health. 2022 Apr; 4(4): e235– 44. 10.1016/S2589-7500(22)00017-6 35272972 · DOI · Paper page
  4. [5]Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022 Jan; 183: 109119. 10.1016/j.diabres.2021.109119 34879977 PMC11057359 · DOI · Paper page
  5. [6]Queiroz MS, de Carvalho JX, Bortoto SF, de Matos MR, das Graças Dias Cavalcante C, Andrade EAS, et al. Diabetic retinopathy screening in urban primary care setting with a handheld smartphone-based retinal camera. Acta Diabetol. 2020 Dec; 57(12): 1493– 9. 10.1007/s00592-020-01585-7 32748176 PMC7398859 · DOI
  6. [8]Malerbi FK, Andrade RE, Morales PH, Stuchi JA, Lencione D, de Paulo JV, et al. Diabetic retinopathy screening using artificial intelligence and handheld smartphone-based retinal camera. J Diabetes Sci Technol. 2022 May; 16(3): 716– 23. 10.1177/1932296820985567 33435711 PMC9294565 · DOI
  7. [9]Cavan D, Makaroff LE, da Rocha Fernandes J, Karuranga S, Sylvanowicz M, Conlon J, et al. Global perspectives on the provision of diabetic retinopathy screening and treatment: survey of health care professionals in 41 countries. Diabetes Res Clin Pract. 2018 Sep; 143: 170– 8. 10.1016/j.diabres.2018.07.004 30003940 · DOI
  8. [10]Javitt JC, Aiello LP, Bassi LJ, Chiang YP, Canner JK; American Academy of Ophthalmology. Detecting and treating retinopathy in patients with type I diabetes mellitus. Savings associated with improved implementation of current guidelines. Ophthalmology. 1991 Oct; 98(10): 1565– 73, discussion 1574. 10.1016/S0161-6420(91)32086-4 1961646 · DOI
  9. [11]Xie Y, Nguyen QD, Hamzah H, Lim G, Bellemo V, Gunasekeran DV, et al. Artificial intelligence for teleophthalmology-based diabetic retinopathy screening in a national programme: an economic analysis modelling study. Lancet Digit Health. 2020 May; 2(5): e240– 9. 10.1016/S2589-7500(20)30060-1 33328056 · DOI · Paper page
  10. [12]Yuan A, Lee AY. Artificial intelligence deployment in diabetic retinopathy: the last step of the translation continuum. Lancet Digit Health. 2022 Apr; 4(4): e208– 9. 10.1016/S2589-7500(22)00027-9 35272973 · DOI
  11. [13]Rajalakshmi R. The impact of artificial intelligence in screening for diabetic retinopathy in India. Eye (Lond). 2020 Mar; 34(3): 420– 1. 10.1038/s41433-019-0626-5 31827270 PMC7055593 · DOI
  12. [14]Abràmoff MD, Cunningham B, Patel B, Eydelman MB, Leng T, Sakamoto T, et al.; Collaborative Community on Ophthalmic Imaging Executive Committee and Foundational Principles of Ophthalmic Imaging and Algorithmic Interpretation Working Group. Foundational considerations for artificial intelligence using ophthalmic Images. Ophthalmology. 2022 Feb; 129(2): e14– 32. 10.1016/j.ophtha.2021.08.023 34478784 PMC9175066 · DOI · Paper page
  13. [15]Nakayama LF, Ribeiro LZ, Malerbi FK, Regatieri CVS. Ophthalmology and artificial intelligence: present or future? A diabetic retinopathy screening perspective of the pursuit for fairness. Front Ophthalmol. 2022; 2: 898181. 10.3389/fopht.2022.898181 PMC11182262 38983555 · DOI

Cited by

Sorted by citations

Authors
Korn Malerbi, F., & Barreto Melo, G.
Venue
Bulletin of the World Health Organization
Publisher
WHO Press
Published
2022-10-01
Volume
100
Issue
10
Pages
643-647
ISSN
0042-9686 (ISSN-L)
OpenAlex
W4300690460
Cited by
33
References
1
Citations by year
2026: 5 · 2025: 5 · 2024: 14 · 2023: 8 · 2022: 1
FWCI
3.98
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Bulletin of the World Health Organization (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Ophthalmology › Ophthalmology and Visual Health Research
Keywords
diabetic retinopathy, retinal screening, artificial intelligence, screening feasibility, health equity, access to eye care, health education, patient attendance, low- and middle-income countries, Brazil, Sergipe, sensitivity and specificity trade-off, public health system
MeSH terms
Artificial Intelligence, Brazil, Diabetes Mellitus, Diabetic Retinopathy, Feasibility Studies, Humans, Pilot Projects

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review